Guocan Wang
Immunology · 2017–2018
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 50 citations into it
Whom Guocan Wang trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Jonathan I. Epstein
- D. Gabrilovich
- D. Hanahan
- Hans Clevers
- Raghu Kalluri
- P. Murray
- T. Jenuwein
- C. D. Allis
- Samir S. Taneja
- F. Lyko
Papers from Guocan Wang's perspective
Ordered by how strongly the researchers Guocan Wang trusts endorse each paper. Same corpus, a different order for every researcher.
- Integrative genomic profiling of human prostate cancer (Cancer Cell)
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (Nature Genetics)
- The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer (Nature)
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer (New England Journal of Medicine)
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer (Nature Genetics)
- Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer (Nature)
- Hallmarks of cancer: the next generation. (Cell)
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer (Science)
- Signatures of mutational processes in human cancer (Nature)
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy (New England Journal of Medicine)
Their papers
- Genetics and biology of prostate cancer (2018) — 641 citations
- Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment (2017) — 1,546 citations